Pharmacovigilance involves several key activities, including:
Adverse Event Reporting: Collecting data on adverse events following immunization (AEFI) from healthcare providers, patients, and manufacturers. Data Analysis: Evaluating the collected data to identify any patterns or signals that may indicate a safety concern. Risk Management: Developing strategies to mitigate any identified risks, such as updating vaccine labels or issuing safety alerts. Communication: Disseminating information about vaccine safety to healthcare providers, regulatory bodies, and the public.
